Search Results 1361-1370 of 17140 for monoclonal antibody

  1. A Study of Sonodynamic Therapy Using SONALA-001 and Exablate 4000 Type 2.0 in Subjects With Recurrent GBM - Mayo Clinic

    Chemotherapy, biologic therapy (i.e., small molecular inhibitors), monoclonal antibodies ... antibody on a shorter frequency (i.e., every two weeks), then the ...

  2. Hematology - Clinical trials

    ... antibodies and the factors that may determine disease progression and treatment response. A Study to Evaluate the Role of Gut Microbiome in Cancer Therapy.

  3. Mayo Clinic Transplant Center - Clinical trials

    The purpose of this study is to investigate how efficiently the study medication imlifidase reduces the amount of donor specific antibodies (DSA) in comparison ...

  4. Study Evaluating ABT-199 in Subjects With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    Serum monoclonal protein ≥ 1.0 g/dL (≥ 10 g/L) by protein electrophoresis;; ≥ 200 mg of monoclonal protein in the urine on 24-hour electrophoresis; or ...

  5. Clinical trials - Oncology (Medical)

    ... antibodies and the factors that may determine disease progression and treatment response. Pagination Clinical studies. PrevPrevious Page · Go to page 1919 · Go ...

  6. Video Center - Mayo Clinic

    Mayo Clinic Video Center features Grand Rounds and other presentations for medical professionals on advances and innovations in patient care, research and ...

  7. BCL2 Inhibitor Venetoclax With Daratumumab-Lenalidomide-Dexamethasone Or Venetoclax-Rd for Newly Diagnosed Multiple Myeloma - Mayo Clinic

    * ≥ 200 mg of monoclonal protein in the urine on 24 hour electrophoresis * ... * Presence of positive hepatitis C antibody ... antibody test are not required to ...

  8. Daratumumab in Cardiac HLA Desensitization Prior to Transplantation - Mayo Clinic

    ... antibodies to total hepatitis B core antigen [anti-HBc] with or without the presence of hepatitis B surface antibody [anti-HBs]) must be screed using real ...

  9. Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3) - Mayo Clinic

    Previous fecal transplant, RBX2660 treatment, receipt of CDI vaccine or treatment with CDI monoclonal antibodies prior to study enrollment. History of ...

  10. Mayo Clinic Minute: What is chimeric antigen receptor-T cell therapy? Chimeric antigen receptor-T cell therapy, also known as CA

    and antibody-based treatments. But for those patients who do not respond to two or more lines of such treatments, CAR-T cell therapy may be an option ...